These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 33711473)
21. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering. Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466 [TBL] [Abstract][Full Text] [Related]
22. Excipient variability and its impact on dosage form functionality. Dave VS; Saoji SD; Raut NA; Haware RV J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249 [TBL] [Abstract][Full Text] [Related]
23. An NIR-based PAT approach for real-time control of loading in Protein A chromatography in continuous manufacturing of monoclonal antibodies. Thakur G; Hebbi V; Rathore AS Biotechnol Bioeng; 2020 Mar; 117(3):673-686. PubMed ID: 31788777 [TBL] [Abstract][Full Text] [Related]
24. Multi-criteria manufacturability indices for ranking high-concentration monoclonal antibody formulations. Yang Y; Velayudhan A; Thornhill NF; Farid SS Biotechnol Bioeng; 2017 Sep; 114(9):2043-2056. PubMed ID: 28464235 [TBL] [Abstract][Full Text] [Related]
25. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions. Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527 [TBL] [Abstract][Full Text] [Related]
26. Computational Characterization of Antibody-Excipient Interactions for Rational Excipient Selection Using the Site Identification by Ligand Competitive Saturation-Biologics Approach. Jo S; Xu A; Curtis JE; Somani S; MacKerell AD Mol Pharm; 2020 Nov; 17(11):4323-4333. PubMed ID: 32965126 [TBL] [Abstract][Full Text] [Related]
27. Effect of protein and solution properties on the Donnan effect during the ultrafiltration of proteins. Bolton GR; Boesch AW; Basha J; Lacasse DP; Kelley BD; Acharya H Biotechnol Prog; 2011; 27(1):140-52. PubMed ID: 21312362 [TBL] [Abstract][Full Text] [Related]
28. Effects of Histidine and Sucrose on the Biophysical Properties of a Monoclonal Antibody. Baek Y; Singh N; Arunkumar A; Zydney AL Pharm Res; 2017 Mar; 34(3):629-639. PubMed ID: 28035628 [TBL] [Abstract][Full Text] [Related]
29. Mass Balance Model with Donnan Equilibrium Accurately Describes Unusual pH and Excipient Profiles during Diafiltration of Monoclonal Antibodies. Baek Y; Singh N; Arunkumar A; Borwankar A; Zydney AL Biotechnol J; 2019 Jul; 14(7):e1800517. PubMed ID: 30791230 [TBL] [Abstract][Full Text] [Related]
30. Near-infrared spectroscopy monitoring and control of the fluidized bed granulation and coating processes-A review. Liu R; Li L; Yin W; Xu D; Zang H Int J Pharm; 2017 Sep; 530(1-2):308-315. PubMed ID: 28743552 [TBL] [Abstract][Full Text] [Related]
31. Developability Assessments of Monoclonal Antibody Candidates to Minimize Aggregation During Large-Scale Ultrafiltration and Diafiltration (UF-DF) Processing. Whitaker N; Pace SE; Merritt K; Tadros M; Khossravi M; Deshmukh S; Cheng Y; Joshi SB; Volkin DB; Dhar P J Pharm Sci; 2022 Nov; 111(11):2998-3008. PubMed ID: 35940242 [TBL] [Abstract][Full Text] [Related]
33. Kinetic Modeling of Methionine Oxidation in Monoclonal Antibodies from Hydrogen Peroxide Spiking Studies. Hui A; Lam XM; Kuehl C; Grauschopf U; Wang YJ PDA J Pharm Sci Technol; 2015; 69(4):511-25. PubMed ID: 26242787 [TBL] [Abstract][Full Text] [Related]
34. Excipient exchange in the comparison of preparations of the same biologic made by different manufacturing processes: an exploratory study with recombinant human growth hormone (rhGH). Cauchy M; Hefford MA Biologicals; 2010 Nov; 38(6):637-43. PubMed ID: 20797874 [TBL] [Abstract][Full Text] [Related]
35. Near-infrared spectroscopic applications in pharmaceutical particle technology. Razuc M; Grafia A; Gallo L; Ramírez-Rigo MV; Romañach RJ Drug Dev Ind Pharm; 2019 Oct; 45(10):1565-1589. PubMed ID: 31282753 [TBL] [Abstract][Full Text] [Related]
36. Ultrafiltration of highly concentrated antibody solutions: Experiments and modeling for the effects of module and buffer conditions. Binabaji E; Ma J; Rao S; Zydney AL Biotechnol Prog; 2016 May; 32(3):692-701. PubMed ID: 26918655 [TBL] [Abstract][Full Text] [Related]
37. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale. Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715 [TBL] [Abstract][Full Text] [Related]
39. Near infrared spectroscopy for rapid and in-line detection of particle size distribution variability in lactose during mixing. Lee WB; Widjaja E; Heng PWS; Chan LW Int J Pharm; 2019 Jul; 566():454-462. PubMed ID: 31170478 [TBL] [Abstract][Full Text] [Related]
40. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations. Garidel P; Pevestorf B; Bahrenburg S Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]